Vancomycin resistance in Staphylococcus aureus

WA McGuinness, N Malachowa… - The Yale journal of …, 2017 - pmc.ncbi.nlm.nih.gov
The evolution of Staphylococcus aureus during the modern antibiotic era has been
delineated by distinct strain emergence events, many of which include acquisition of …

Polymyxin and lipopeptide antibiotics: membrane-targeting drugs of last resort

EVK Ledger, A Sabnis, AM Edwards - Microbiology, 2022 - microbiologyresearch.org
The polymyxin and lipopeptide classes of antibiotics are membrane-targeting drugs of last
resort used to treat infections caused by multi-drug-resistant pathogens. Despite similar …

Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains …

BP Howden, JK Davies, PDR Johnson… - Clinical microbiology …, 2010 - journals.asm.org
The emergence of vancomycin-intermediate Staphylococcus aureus (VISA) and
heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) over the past …

Cellular impermeability and uptake of biocides and antibiotics in Gram‐positive bacteria and mycobacteria

PA Lambert - Journal of applied microbiology, 2002 - academic.oup.com
Gram‐positive bacteria possess a permeable cell wall that usually does not restrict the
penetration of antimicrobials. However, resistance due to restricted penetration can occur …

[HTML][HTML] The emergence of antibiotic resistance by mutation

N Woodford, MJ Ellington - Clinical Microbiology and Infection, 2007 - Elsevier
The emergence of mutations in nucleic acids is one of the major factors underlying
evolution, providing the working material for natural selection. Most bacteria are haploid for …

Influence of Vancomycin Minimum Inhibitory Concentration on the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

A Soriano, F Marco, JA Martínez, E Pisos… - Clinical Infectious …, 2008 - academic.oup.com
Background. Vancomycin treatment failure in methicillin-resistant Staphylococcus aureus
(MRSA) bacteremia is not uncommon, even when MRSA is susceptible to vancomycin. The …

Antibacterial photodynamic therapy in dermatology

T Maisch, RM Szeimies, G Jori, C Abels - … & Photobiological Sciences, 2004 - pubs.rsc.org
Photodynamic therapy (PDT) appears to be endowed with several favourable features for
the treatment of localized microbial infections, especially after the advent of cationic …

Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus

FC Tenover, JW Biddle… - Emerging infectious …, 2001 - pmc.ncbi.nlm.nih.gov
Strains of Staphylococcus aureus with reduced susceptibility to glycopeptides have been
reported from Japan, the United States, Europe, and the Far East. Although isolates with …

Staphylococcus epidermidis device‐related infections: pathogenesis and clinical management

MT McCann, BF Gilmore… - Journal of Pharmacy and …, 2008 - Wiley Online Library
Staphylococcus epidermidis, the most frequently isolated coagulase‐negative
staphylococcus, is the leading cause of infection related to implanted medical devices …

Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides

TR Walsh, A Bolmström… - Journal of clinical …, 2001 - journals.asm.org
The sensitivity and specificity of seven methods (agar dilution, broth microdilution, Etest at
0.5 and 2.0 McFarland (McF) inocula, two agar screening methods, and population studies …